4Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal caner after resection and intraoperative radiothrerapy. Dis Colon Rectum,2002,45:585-592.
3Maurer CA, Renzulli P, Kasparek MS, et al. The role of lymph nodes in colon carcinoma. Zentralbl Chir, 2000, 125:863-869.
4Leroy J, Jamali F, Forbes L, et al. Laparescopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes.Surg Endosc, 2004, 18:281-289.
5Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiothrerapy. Dis Colon Rectum, 2002, 45:585-592.
6Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg, 2003, 237: 502-508.
7Bakx R, van Tinteren H, van Lanschot JJ, et al. Surgical treatment of locally recurrent rectal cancer. Eur J Surg Oncol,2004, 30: 857-863.
8Masui H, Ike H, Yamaguchi S, et al. Male sexual function after autonomic nerve- preserving operation for rectal cancer. Dis Colon Rectum, 1996, 39: 1140-1145.
9Toumigand C, Andre T, AchiUe E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:a randomized GERCOR study. J Clin Oncol, 2004, 22 : 229-237.
10Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg, 1996, 224:509-520.
